The U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleuecel (Tecelra®, also known as afami-cel) for the treatment of adults with a rare soft tissue cancer called synovial sarcoma.
Ultrasound May Help Early Breast Cancer Patients Avoid SLNB
Omitting axillary surgery completely in early breast cancer patients with a negative preoperative axillary ultrasound resulted in similar outcomes compared with sentinel lymph node biopsy